ABOUT US
Nanjing Hengdao Pharmaceutical Technology Co., Ltd.
Pharmaceuticals & Medical Devices | Full-Chain MAH + CXO + CDMO Services | Innovation Layer of NEEQ (Stock Code: 873870)
COMPANY
Company Profile
Nanjing Hengdao Medical Technology Co., Ltd. is a comprehensive service provider offering end-to-end solutions for health and beauty products—including project initiation, R&D, technical services, manufacturing, registration, commercialization, and sales. We offer a wide range of consumer-grade pharmaceuticals and medical devices available for full-spectrum collaboration.
By the end of 2023, the company partnered with Jiangsu Tianping Pharmaceutical, located in Yangzhou National High-tech Zone. We are building a new modern, intelligent R&D and production base spanning over 80000 square meters. The facility includes more than 10 workshops for various dosage forms covering Chinese medicine, chemical drugs, and medical devices. Equipped with state-of-the-art precision manufacturing equipment and testing instruments, the site will house a professional team of over 100 employees.
AT A GLANCE
Core Strengths, Proven by Data
Factory floor area
R&D Center
MAH-listed drugs
R&D personnel
Instruments and Equipment
Class II device launch
Selected for National Centralized Procurement
Production Line
CAPABILITIES
Key Advantages
End-to-end CDMO services
End-to-end custom contract manufacturing from R&D and technology transfer to mass production and quality assurance—reducing coordination costs across multiple stages.
Diversified Smart Production Lines
Four product lines covering TCM, conventional pharmaceuticals, medical devices, and aesthetic medicine; supporting diverse processes and packaging materials with custom production line collaboration options.
Innovation driven by R&D
Leveraging Hengdao Pharma's R&D platform, with 100+ professional researchers and 500+ state-of-the-art instruments, we deliver end-to-end R&D capabilities from formulation development to process scale-up.
Rigorous Quality System
Holdings of comprehensive authoritative certifications including MAH holder system, pharmaceutical GMP, ISO13485 medical device system, and CNAS national laboratory accreditation.
BUSINESS
Core B2B Business Segments
Pharmaceuticals, Medical Devices & Health CRO Services
Covering chemical drugs (Classes 1-4), traditional Chinese medicines (Classes 1-4), medical devices (Classes 1-3), and big health products (disinfectants, efficacy cosmetics, enterprise standards). We provide end-to-end technical services including project initiation assessment, prescription process development, impurity research, stability testing, regulatory supplement studies, and full registration filing, ensuring high approval success rates even under strict review conditions.
CDMO Manufacturing
Yangzhou 9 sqm industrial base covering pharmaceuticals, medical devices, and health & wellness. Enables full-scale commercialization from lab R&D to pilot testing and mass production. Offers personalized services for various batch sizes and supports joint R&D, contract manufacturing, ODM, and OEM partnerships.
CNAS Third-Party Inspection and Testing
Provides testing and inspection for raw materials, auxiliary materials, packaging materials, product release, and stability studies. Short turnaround times, precise data, and full-cycle compliance support for regulatory review.
MAH Holder Platform + License Transfer & Product Sales
License transfers and full-lifecycle project management; sales partnerships, OEM/ODM services for pharmaceuticals, medical devices, and broader health products.
CERTIFICATIONS
Core Qualifications & Corporate Honors
Enterprise Certification
- National High-Tech Enterprise
- Jiangsu Province Specialized and New "Little Giant"
- R&D Enterprises in Jiangsu Province
- Nanjing Gazelle Enterprise
- New Third Board Innovation Layer
System Certification
- CNAS National Laboratory Accreditation
- Drug GMP
- ISO 13485 Medical Device Quality Management System
- Intellectual Property Management System Certification
Industry Platform
- Jiangsu Province MAH Platform
- Liquid Formulation Engineering Research Center
MILESTONES
History
Jiangsu Tianping Pharmaceutical Co., Ltd. Established
Nanjing Hengdao Pharmaceutical Technology Co., Ltd. established
GMP-certified; Traditional Chinese Medicine production line officially launched
Chemical solid dosage production line completed and launched
Nanjing Hengdao Medicine Completes Full Acquisition of Jiangsu Tianping Pharmaceutical
Medical device production line completed; 100,000-grade cleanroom now operational
Launch of the medical aesthetics product line; CDMO business fully operational.
Partner to build a new 80000+ sqm modern, intelligent R&D and production base
Recognized as a High-Tech Enterprise and Jiangsu Province's "Little Giant" Specialized and New SME
Over 100+ projects commercialized, with over 20+ projects ranked in the top 3 domestically for approval.
Listed on the Innovation Layer of NEEQ; Total Revenue: 6500.17 (10,000 CNY)
ROADMAP
Future Development Direction
Accelerate pipeline conversion
Following the semi-annual report disclosure, Povidone-Iodine Eye Drops and Levocabastine Oral Solution received approval, while the OTC blockbuster Glucosamine Sulfate Capsules were successfully accepted for review. Other drug projects are progressing steadily.
Breakthroughs in Ophthalmic & Aesthetic Devices
Multiple Class III ophthalmic devices have completed their first commercial shipments. Development of Class III aesthetic medical products has entered a critical phase, while new Class II aesthetic medical products continue to launch.
Commercial distribution scaling
Continue advancing commercial distribution of MAH products and maximize platform operational value.
Strengthen the full MAH + CXO value chain
Leverage the Yangzhou Tianping base's production capacity advantages to expand CRO and CDMO project portfolios and strengthen complex solvent-free delivery capabilities.
Traditional Chinese Medicine sector
Position technology services and the commercialization of innovative intrahospital preparations as our core focus.
Amplify the Value of the MAH Holder Platform
Strengthen the operation and commercial distribution of drug and device approvals, advance the launch of our proprietary pipeline, and expand our product portfolio.
Upgrade CNAS Testing and Inspection
Strengthen the closed-loop integration of R&D, production, inspection, and sales, while expanding into the third-party testing market.
Build your own Da Ke Xian brand
Solidify Wuxian Baoyan's position as a top eye health product, expand the skincare and ophthalmic care portfolio, and build an eye health & repair skincare brand with a pharmaceutical background through online content marketing, e-commerce, and offline medical aesthetics and pharmacy channels.
Launch cross-border business operations
ToB Global Expansion: Leverage our robust R&D and manufacturing capabilities to establish international partnerships for overseas drug, medical device, and health product development and custom production. ToC Global Expansion: Drive the global growth of the Kexian brand by exporting ophthalmology and dermatology product lines to expand into overseas consumer markets.
VISIT
Schedule a visit
Tour our production lines, quality management system, and pipeline of products in development.